# Fidelity Ethereum Fund: financial statements, quarterly

FETH · CBOE · CIK 2000046 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/feth.md) · [Financials](/companies/feth/financials.md) · [Filings](/companies/feth/filings.md) · [Insiders](/companies/feth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/feth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(58.6)](/filings/0001193125-25-271731.md) | [(665)](/filings/0001193125-26-208449.md) | [247](/filings/0001193125-26-337675.md) | [873](/filings/0001193125-25-271731.md) | [(877) d](/filings/0001193125-26-071486.md) | [(662)](/filings/0001193125-26-208449.md) | [(255)](/filings/0001193125-26-337675.md) |

- Net income: us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | Q2 FY2025 (2024-06-30) | Q3 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [4.4](/filings/0000950170-24-100125.md) | [424](/filings/0000950170-24-126257.md) | [1,604](/filings/0001193125-26-071486.md) | [740](/filings/0000950170-25-067925.md) | [1,265](/filings/0000950170-25-105581.md) | [3,155](/filings/0001193125-25-271731.md) | [2,212](/filings/0001193125-26-337675.md) | [1,214](/filings/0001193125-26-208449.md) | [759](/filings/0001193125-26-337675.md) |
| Total liabilities | $m | [0.0](/filings/0000950170-24-100125.md) | [0.0](/filings/0000950170-24-126257.md) | [31.8](/filings/0001193125-26-071486.md) | [6.6](/filings/0000950170-25-067925.md) | [25.9](/filings/0000950170-25-105581.md) | [0.7](/filings/0001193125-25-271731.md) | [2.7](/filings/0001193125-26-337675.md) | [1.8](/filings/0001193125-26-208449.md) | [0.2](/filings/0001193125-26-337675.md) |
| Shareholders' equity | $m | [4.4](/filings/0000950170-24-100125.md) | [424](/filings/0000950170-24-126257.md) | [1,573](/filings/0001193125-26-071486.md) | [734](/filings/0000950170-25-067925.md) | [1,239](/filings/0000950170-25-105581.md) | [3,154](/filings/0001193125-25-271731.md) | [2,210](/filings/0001193125-26-337675.md) | [1,212](/filings/0001193125-26-208449.md) | [759](/filings/0001193125-26-337675.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [148](/filings/0001193125-26-208449.md) | [(239) d](/filings/0001193125-26-337675.md) | [(1,067) d](/filings/0001193125-25-271731.md) | [120 d](/filings/0001193125-26-071486.md) | [177](/filings/0001193125-26-208449.md) | [93.3 d](/filings/0001193125-26-337675.md) |
| Share repurchases | $m | [530](/filings/0001193125-26-208449.md) | [260 d](/filings/0001193125-26-337675.md) | [1,654 d](/filings/0001193125-25-271731.md) | [819 d](/filings/0001193125-26-071486.md) | [719](/filings/0001193125-26-208449.md) | [411 d](/filings/0001193125-26-337675.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 47,375,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337675.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.